Palladia - Effective Treatment for Mast Cell Tumors in Dogs

Palladia is an FDA-approved oral medication used for the treatment of mast cell tumors (MCTs) in dogs, a common type of cancer found in canine patients. The active ingredient in Palladia, Toceranib Phosphate, is a tyrosine kinase inhibitor that works by blocking the signals responsible for tumor growth. By targeting these signals, Palladia can slow the progression of mast cell tumors and help manage the cancer in dogs.

 

Mast cell tumors are often diagnosed through biopsies and are known for causing symptoms such as swelling, pain, and discomfort. Palladia helps treat these tumors by inhibiting angiogenesis (the formation of new blood vessels) and preventing tumor cells from multiplying. It is primarily used when surgery or radiation therapy alone is not sufficient or possible. Palladia not only works to reduce tumor size but can also improve the overall quality of life for dogs diagnosed with cancer.

 

Palladia is administered in tablet form, typically given once a day according to the dosage prescribed by your veterinarian. The dosage will depend on your dog’s weight and the severity of the cancer. Regular veterinary check-ups are essential for monitoring your dog’s condition and ensuring the treatment’s effectiveness. Palladia has shown significant success in managing mast cell tumors, offering dogs a better chance at extended survival and improved quality of life.

 

Key Benefits:

• FDA-approved treatment for mast cell tumors in dogs.

• Inhibits tumor growth and prevents the formation of new blood vessels.

• Available in tablet form, making administration straightforward.

• Improves overall quality of life by reducing tumor size and symptoms.

• Ideal for dogs with mast cell tumors when surgery or radiation is insufficient.

• Helps extend survival in dogs diagnosed with mast cell tumors.